Michael Poulter Ph.D.
(Former Chief Scientific Officer and Professor, Robarts Research Institute, University of Western Ontario)
Dr. Michael Poulter passed away unexpectedly on August 10, 2019 following a brief illness. His loss only strengthens OB Pharmaceuticals resolve to see his novel research translate to benefit those patients suffering from epilepsy and other seizure related disorders.
Professor Poulter’s work for the past 20 years has focussed on brain function as it relates to epilepsy, as well as major depressive disorder. He has published over 65 peer-reviewed articles. He has an international reputation for his work and is highly cited by his colleagues. He has also been very active is promoting epilepsy research by acting as the president of Canadian Epilepsy Research Initiative (2006-2013) and served as associate editor for the Canadian Journal of Neurological Sciences 2008-2014. He also serves as a director of Epilepsy Canada.
Michael Poulter received his B.Sc. in Pharmacology and Therapeutics in 1985 from the University of British Columbia and his PhD in Pharmacology from McGill University in 1990. He was awarded a Fogarty International Fellowship to do postdoctoral research at the National Institute of Neurological Disorders and Stroke at the National Institutes of Health in Bethesda, Maryland. In 1992 he was awarded an International Fellowship from the Government of France to conduct research at the Université Louis Pasteur, Strasbourg France. In 1995 he returned to Canada to head his first laboratory at the National Research Council’s facilities in Ottawa. In 2001 he took up an academic position at the Institute for Neuroscience at Carleton University where he became head of the Institute in 2003. In 2006 he accepted a scientist position at the Robarts Research Institute in London, Ontario, Canada. He was also appointed to the University of Western Ontario’s Department of Physiology and Pharmacology as full professor in 2008.